UAE issues urgent warning over counterfeit Botox batch
EDE warned that the use of counterfeit products may pose a serious risk to public health
Dubai: The Emirates Drug Establishment (EDE) has issued an urgent warning regarding a counterfeit batch of Botox Cosmetic for Injection 100 Units bearing batch number "C7048C4", after confirming that the batch number does not match the records of AbbVie, the US manufacturer of the product.
The Establishment noted that the product was not imported through the official channels approved by the Establishment.
Get updated faster and for FREE: Download the Gulf News app now - simply click here.
EDE warned that the use of such counterfeit products may pose a serious risk to public health, as they do not comply with approved specifications and could result in harmful health reactions or unforeseen complications.
The Emirates Drug Establishment called on healthcare providers, pharmacies and medical facilities to carefully verify the authenticity of medical products before using or dispensing them, and to immediately cease the use, distribution or circulation of any units carrying the specified batch number.
EDE also advised patients to consult a physician or pharmacist if they experience any unusual symptoms following use, and emphasised the importance of reporting any suspected products or irregular activities related to the distribution or handling of this batch.
For enquiries or to report suspected cases, the public and healthcare professionals may contact the National Medical Products Vigilance Department at the Emirates Drug Establishment via email at: info@ede.gov.ae.
